Journal
LANCET ONCOLOGY
Volume 5, Issue 4, Pages 209-218Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(04)01424-X
Keywords
-
Categories
Funding
- NCI NIH HHS [CA96832-01, CA21765] Funding Source: Medline
Ask authors/readers for more resources
Medulloblastoma is the most common malignant brain tumour that occurs during childhood. Multimodality treatment regimens have substantially improved survival in this disease; however, the tumour is incurable in about a third of patients with medulloblastoma, and current treatment has a detrimental effect on long-term survivors. Drugs that target cell-signalling pathways provide an alternative to conventional cytotoxic approaches to treatment of cancer. Several pathways have been implicated in medulloblastoma formation, and knowledge of these is now being used to develop new ways of treating children with medulloblastoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available